Article
Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer.
Department of Nanobiomedical Science and WCU Research Center of Nanobiomedical Science Dankook University Cheonan, Republic of Korea Department of Oncology Lombardi Comprehensive Cancer Center Georgetown University Washington, DC and Department of Nanobiomedical Science and WCU Research Center of Nanobiomedical Science Dankook University Cheonan, Republic of Korea Department of Obstetrics and Gynecology Keimyung University School of Medicine Daegu, Korea Department of Nanobiomedical Science and WCU Research Center of Nanobiomedical Science Dankook University Cheonan, Republic of Korea Department of Oncology and Department of Radiation Medicine Lombardi Comprehensive Cancer Center Georgetown University Washington DC and Department of Nanobiomedical Science and WCU Research Center of Nanobiomedical Science Dankook University Cheonan, Republic of Korea .
Pancreas (impact factor:
2.39).
07/2012;
41(5):804-5.
DOI:10.1097/MPA.0b013e31823f3fcb
pp.804-5
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
